Secarna Pharmaceuticals
Pre-clinicalWith OligoCreator®, our AI-empowered drug discovery platform, we deliver on our mission to transform untreatable conditions into treatable ones, profoundly changing the future of medicine.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $120M
About
With OligoCreator®, our AI-empowered drug discovery platform, we deliver on our mission to transform untreatable conditions into treatable ones, profoundly changing the future of medicine.
RNA & Gene Therapy
Funding History
3Total raised:$120M
Series C$60MJun 15, 2022
Series B$40MJan 15, 2020
Series A$20MOct 15, 2017